Beta-lactams, cephalosporins and broad-spectrum anti-infectives across oral solid, liquid and sterile injectable forms.
Anti-infectives represent Finecure’s deepest manufacturing commitment. The range spans amoxicillin and amoxicillin-clavulanate from a dedicated plant with a 100% isolated block, cephalosporin oral solids from a segregated block, and third-generation cephalosporin injectables from a separate facility inspected to PIC/S GMP standards. Segregation here is structural rather than procedural: independent air handling, independent personnel flow, independent equipment trains. Partners receive documentation traceable to the specific block in which each batch was produced.
Our DSIR-approved R&D center continuously executes complex technology transfers and formulation development. If your required therapeutic is not listed in our active commercial matrix, contact our technical team to initiate a custom Contract Manufacturing (CDMO) project.
Submit CDMO / Tech-Transfer Inquiry
